Lilly To Pay Up To $500 Million In Second Zyprexa Settlement
The settlement resolves suits alleging Lilly inadequately warned patients of the risks of diabetes and hyperglycemia associated with the antipsychotic.
The settlement resolves suits alleging Lilly inadequately warned patients of the risks of diabetes and hyperglycemia associated with the antipsychotic.